Atomic-scale imperfections in graphene transistors generate unique wireless fingerprints that cannot be copied or predicted, ...

"Managing a technical operations budget in today’s broadcast marketplace is challenging and can be time-consuming," says Tim ...

Xenon Pharmaceuticals (XENE) is undervalued given azetukalner's late-stage potential to transform epilepsy and mood disorder ...

Driving the Singer Vehicle Design Turbo ► Exploring the Golden State ► Have we found driving nirvana? Keys to special machines have been flung my way before; LaFerrari Ape ...

Photonic computing represents not a radical departure from familiar territory, but rather a natural extension along the electromagnetic spectrum. The transition from gigahertz to hundreds of terahertz ...

OV350 showed a good safety profile, supporting the advancement of the Company’s KCC2 portfolio, including the first oral ...

Pulsetto is a non-invasive vagus nerve stimulation device designed to support stress balance, sleep readiness, and nervous ...

CES 2026 is just around the corner and we will be there again but, looking back, our 2025 coverage was very popular. Though ...

EMBOLD data to serve as basis of efficacy and safety following discussion with the FDABOSTON, Dec. 11, 2025 (GLOBE NEWSWIRE) ...

SandboxAQ and MapLight Therapeutics, Inc. (Nasdaq: MPLT) announced today that the companies have entered into a strategic collaboration to discover and develop potential first-in-class therapies ...

Positive Results in the EMBOLD study of relutrigine showed a 53% placebo-adjusted reduction in seizures (p < 0.0002), 66% increase in motor ...